# Investigate the Effect of AZD1305 on Patients With Left Ventricular Dysfunction

> **NCT00748982** · PHASE2 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 16 (actual)

## Conditions studied

- Left Ventricle Function

## Interventions

- **DRUG:** AZD1305
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00748982
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2011-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00748982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00748982, "Investigate the Effect of AZD1305 on Patients With Left Ventricular Dysfunction". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00748982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*